Modulation of associated ovarian carcinoma antigens by 5 cytokines used as single agents or in combination
Berthe‐Marie Imbert‐Marcille(Inserm), J.F. Chatal, Catherine Saï‐Maurel(Inserm), Jean-Louis Auget(Laboratoire Physiologie Biotechnologie des Algues), Christine François(Inserm), Philippe Thédrez(Inserm), Y. Jacques(Inserm), Jean Bénard(Institut Gustave Roussy), Shunsuke Imai(RIKEN Center for Integrative Medical Sciences)
Cited by 3
Related Papers
A dose-controlled study of 153Sm-Ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastase
|European Journal of Cancer|1997|254
Summary Report on the ISOBM TD-4 Workshop: Analysis of 56 Monoclonal Antibodies against the MUC1 Mucin
|Tumor Biology|1998|216
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study
|The Lancet Oncology|2009|196
Crocetin prevents retinal degeneration induced by oxidative and endoplasmic reticulum stresses via inhibition of caspase activity
|European Journal of Pharmacology|2010|156
Prognostic Impact of Gene Expression–Based Classification for Neuroblastoma
|Journal of Clinical Oncology|2010|130